AVM Biotech
Former CEO AGC Biologics. Dr. Mahler received his Ph.D. in Biochemistry from the University of Buenos Aires, MBA from the University UNED of Madrid, and an Executive Certification in Management from MIT Sloan.
This person is not in the org chart
This person is not in any offices
AVM Biotech
5 followers
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.